Skip to main content

AVGR

Stock
Health Care
Medical Instruments & Supplies

Performance overview

AVGR Price
Price Chart

Forward-looking statistics

Beta
1.08
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees84
Market cap$3.3M

Fundamentals

Enterprise value
Revenue
Revenue per employee
Profit margin
Debt to equity

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)
Dividend per share
Revenue per share
Avg trading volume (30 day)
Avg trading volume (10 day)
Put-call ratio

Macro factor sensitivity

Growth+7.3
Credit+2.6
Liquidity-3.4
Inflation+8.6
Commodities+2.0
Interest Rates-0.7

Valuation

Dividend yield0.00%
PEG Ratio
Price to sales
P/E Ratio
Enterprise Value to Revenue
Price to book

Upcoming events

Next earnings day
Next dividend day
Ex. dividend day

News

Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates

Avinger (AVGR) came out with a quarterly loss of $1.82 per share versus the Zacks Consensus Estimate of a loss of $2.03. This compares to loss of $2.92 per share a year ago.

Zacks Investment Research (November 7, 2024)
Avinger Registers 12% Decline In Q4 Revenue, Says Hospital Constraints Impacted Q4

Avinger Inc (NASDAQ: AVGR) reported a fourth-quarter revenue decrease of 12% year-over-year to $2.40 million, beating the consensus of $2.29 million. Hospital constraints impacted Q4 on procedural volume and hospital staffing shortages related to the resurgence of COVID-1.

Benzinga (March 22, 2022)
Top Companies To Short In A Potentially Overbought Market

There are pockets of the stock market that look far too overvalued to ignore, and our deep learning algorithms paired with our Artificial Intelligence ('AI') technology has identified the top short targets for today.

Forbes (June 4, 2020)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free